Wojciech Lesniak

4PUBLICATIONS
13CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Pharmaceutical delivery technologiesReaction engineering (excl. nuclear reactions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 04, 2024
Multimodal, PSMA-Targeted, PAMAM Dendrimer-Drug Conjugates for Treatment of Prostate Cancer: Preclinical Evaluation.

Wojciech G Lesniak, Srikanth Boinapally, Gabriela Lofland

|Oct 27, 2021
Dual-Modality PET-SPECT Image-Guided Pretargeting Delivery in HER2(+) Breast Cancer Models.

Sudath Hapuarachchige, Ge Si, Colin T Huang

|Apr 20, 2019
Evaluation of PSMA-Targeted PAMAM Dendrimer Nanoparticles in a Murine Model of Prostate Cancer.

Wojciech G Lesniak, Srikanth Boinapally, Sangeeta Ray Banerjee

|Aug 05, 2017
Chemogenetics revealed: DREADD occupancy and activation via converted clozapine.

Juan L Gomez, Jordi Bonaventura, Wojciech Lesniak

Pageof 1

Frequent Collaborators

1 joint publications

Sangeeta Ray Banerjee

1 joint publications

Sridhar Nimmagadda

1 joint publications

Martin G Pomper

1 joint publications

Sudath Hapuarachchige